Funded Tech Companies

Kyverna Therapeutics

Researching who invested in Kyverna Therapeutics? Oxford Finance, CAM Capital and Insight Venture Partners put venture money into this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

We are a cell therapy company developing a new class of treatments and potential cures for serious autoimmune diseases. Autoimmune diseases result from a failure of the immune system to distinguish self from non-self, caused by autoreactive B cells and T cells attacking the body's own tissues.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/3/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dominic Borie

        

Chief Scientific Officer

Jeffrey Greve

        

VP - General Counsel

Gregory Giotta

        

VP - Operations

Ryan Jones

        

Company Investors

• Oxford Finance (Kirk Andrews)
• CAM Capital
• Insight Venture Partners
• Lyfe Capital
• Westlake Village BioPartners (Beth Seidenberg)
• GordonMD Global Investments
• Bain Capital Life Sciences
• Northpond Ventures (Shaan Gandhi)
• Vida Ventures (Fred Cohen)
• RTW Investments (Chris Liu)
• Gilead Sciences (Mark Genovese)
• jVen Capital
• Intellia Therapeutics
• Argentum Capital Partners
• HealthCor Partners
• Hudson Bay Capital

Browse more funded tech companies:

Kyulux | KYX World

Share this article

About Our VC Transaction Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary